Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
Sponsor: HighTide Therapeutics (Hong Kong) Limited
Summary
Randomized, double-blind, placebo-controlled, parallel-group study comparing multiple doses of HTD1801 to placebo.
Official title: A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adults With NASH and T2DM
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
101
Start Date
2018-11-26
Completion Date
2020-03-09
Last Updated
2026-08-25
Healthy Volunteers
No
Conditions
Interventions
HTD1801
HTD1801 tablets, 250mg
Placebo
tablets manufactured to mimic HTD1801 tablets
Locations (17)
Institute for Liver Health
Chandler, Arizona, United States
Institute for Liver Health
Tucson, Arizona, United States
Adobe Clinical Research
Tucson, Arizona, United States
National Research Institute
Panorama City, California, United States
Excel Medical Clinical Trials
Boca Raton, Florida, United States
Florida Research Institute
Lakewood Rch, Florida, United States
Compass Research
Orlando, Florida, United States
Kansas City Research Institute
Kansas City, Missouri, United States
Cumberland Research Associates
Fayetteville, North Carolina, United States
Gastro One
Germantown, Tennessee, United States
Digestive Health Research
Hermitage, Tennessee, United States
Pinnacle Clinical Research
Austin, Texas, United States
Doctors Hospital at Renaissance
Edinburg, Texas, United States
Pinnacle Clinical Research
San Antonio, Texas, United States
Texas Digestive Disease Consultants
Southlake, Texas, United States
Harborview Medical Center
Seattle, Washington, United States
University of Washington Medical Center
Seattle, Washington, United States